Skip to main content

Empiric Definition of Eligibility Criteria for Clinical Trials in Relapsed/Refractory AML: Analysis of 1,892 Patients from HOVON/SAKK and SWOG

Publication ,  Conference
Walter, RB; Othus, M; Loewenberg, B; Ossenkoppele, GJ; Petersdorf, SH; Pabst, T; Vekemans, M-C; Appelbaum, FR; Erba, HP; Estey, EH
Published in: BLOOD
December 6, 2014

Duke Scholars

Published In

BLOOD

EISSN

1528-0020

ISSN

0006-4971

Publication Date

December 6, 2014

Volume

124

Issue

21

Location

San Francisco, CA

Publisher

AMER SOC HEMATOLOGY

Conference Name

56th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Walter, R. B., Othus, M., Loewenberg, B., Ossenkoppele, G. J., Petersdorf, S. H., Pabst, T., … Estey, E. H. (2014). Empiric Definition of Eligibility Criteria for Clinical Trials in Relapsed/Refractory AML: Analysis of 1,892 Patients from HOVON/SAKK and SWOG. In BLOOD (Vol. 124). San Francisco, CA: AMER SOC HEMATOLOGY.
Walter, Roland B., Megan Othus, Bob Loewenberg, Gert J. Ossenkoppele, Stephen H. Petersdorf, Thomas Pabst, Marie-Christianne Vekemans, Frederick R. Appelbaum, Harry P. Erba, and Elihu H. Estey. “Empiric Definition of Eligibility Criteria for Clinical Trials in Relapsed/Refractory AML: Analysis of 1,892 Patients from HOVON/SAKK and SWOG.” In BLOOD, Vol. 124. AMER SOC HEMATOLOGY, 2014.
Walter RB, Othus M, Loewenberg B, Ossenkoppele GJ, Petersdorf SH, Pabst T, et al. Empiric Definition of Eligibility Criteria for Clinical Trials in Relapsed/Refractory AML: Analysis of 1,892 Patients from HOVON/SAKK and SWOG. In: BLOOD. AMER SOC HEMATOLOGY; 2014.
Walter RB, Othus M, Loewenberg B, Ossenkoppele GJ, Petersdorf SH, Pabst T, Vekemans M-C, Appelbaum FR, Erba HP, Estey EH. Empiric Definition of Eligibility Criteria for Clinical Trials in Relapsed/Refractory AML: Analysis of 1,892 Patients from HOVON/SAKK and SWOG. BLOOD. AMER SOC HEMATOLOGY; 2014.

Published In

BLOOD

EISSN

1528-0020

ISSN

0006-4971

Publication Date

December 6, 2014

Volume

124

Issue

21

Location

San Francisco, CA

Publisher

AMER SOC HEMATOLOGY

Conference Name

56th Annual Meeting of the American-Society-of-Hematology

Related Subject Headings

  • Immunology
  • 3213 Paediatrics
  • 3201 Cardiovascular medicine and haematology
  • 3101 Biochemistry and cell biology
  • 1114 Paediatrics and Reproductive Medicine
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology